Lab-on-Chip Patents

Lab-on-chip patents span microfluidic chip design and fabrication; droplet generation; single-cell encapsulation; nucleic acid amplification on chip; sequencing chip technology; and organ-on-a-chip biology — with concentrated IP in sequencing platforms; single-cell genomics; digital PCR; and organ simulation: MAJOR LAB-ON-CHIP PATENT HOLDERS: ILLUMINA: 5,000+; specific flow cell sequencing chip (specific specific patterned flow cell: specific specific nanowell array on glass substrate for specific specific clustered amplicon confined SBS sequencing-by-synthesis with specific specific 4-color or specific specific 2-color fluorophore-labeled reversible terminator dNTP; specific specific cBot cluster generation by specific specific bridge amplification from specific specific P5+P7 surface oligonucleotide for specific specific polonies 1-3μm diameter; specific specific CMOS image sensor beneath specific specific flow cell for specific specific direct fluorescence detection in specific specific HiSeq/NovaSeq X; specific specific ExAmp enzyme chemistry for specific specific patterned nanowells for specific specific high-cluster density); 10X GENOMICS: 500+; specific Chromium GEM single-cell platform (specific specific microfluidic chip generating specific specific Gel-in-Emulsion GEM: specific specific 1nL emulsion droplet encapsulating specific specific single cell + specific specific gel bead from specific specific barcoded oligonucleotide library for specific specific single-cell RNA-seq + specific specific ATAC-seq + specific specific spatial transcriptomics Visium 55μm spot array; specific specific 10-second droplet generation rate 8-channel parallel for specific specific 10,000+ cell/run throughput); FLUIDIGM (STANDARD BIOTOOLS): 500+; specific Integrated Fluidic Circuit IFC (specific specific multilayer PDMS microfluidic chip with specific specific on-chip valve from specific specific Quake push-down valve technology for specific specific single-cell capture + specific specific RNA-seq library prep; specific specific C1 chip 800-6,200μm capture site for specific specific single-cell trapping; specific specific Digital Array chip 770-panel digital PCR 12-panel for specific specific 765+4-chamber partition); BIONANOMATRIX/BIONANO GENOMICS: 200+; specific nanochannel chip for specific specific optical genome mapping OGM (specific specific 100nm-wide nanochannel etched silicon chip for specific specific long DNA molecule 150kb-10Mb stretching + specific specific fluorescent label pattern for specific specific SV structural variant detection at specific specific 500bp resolution); EMULATE INC. (WYSS INSTITUTE SPINOUT): 100+; specific organ-on-a-chip (specific specific two-PDMS-channel chip with specific specific ECM-coated porous membrane 10μm pore 50μm thick for specific specific epithelial+endothelial co-culture at specific specific air-liquid interface + specific specific cyclic mechanical stretch actuation at specific specific 10% 0.2 Hz for specific specific lung alveolar or specific specific intestinal peristalsis organ physiology simulation); PACIFIC BIOSCIENCES PACBIO: 500+; specific SMRT cell (specific specific zero-mode waveguide ZMW: specific specific sub-attoliter optical nanowell aluminum cladding 100nm diameter for specific specific single polymerase molecule real-time sequencing from specific specific phospholinked fluorescent nucleotide); OXFORD NANOPORE: 500+; specific nanopore array chip (specific specific protein pore MspA+CsgG inserted in specific specific synthetic lipid bilayer suspended on specific specific ASIC chip well for specific specific single-molecule ionic current sequencing base calling).

PDMS microfluidic fabrication methods; droplet generation and control; and digital PCR chip partitioning represent three foundational IP areas in lab-on-chip technology where specific fabrication processes; chip architectures; and quantification methods create meaningful competitive moats: PDMS MICROFLUIDIC FABRICATION PATENTS: CALTECH (QUAKE LAB); HARVARD (WHITESIDES LAB); MIT; STANFORD; UNIVERSITY OF TORONTO: specific multilayer PDMS soft lithography (specific specific spin-coat PDMS GE RTV615 A:B 5:1 control layer + specific specific 20:1 flow layer; align+bond under specific specific 80°C 2h for specific specific multilayer valve-based chip; specific specific push-down valve: specific specific pressurized square 100μm control channel collapses specific specific 100μm round flow channel at specific specific 15 psi for specific specific <1ms closure time; specific specific multiplexed valve array: specific specific 2^n combinations from specific specific n binary valve for specific specific cell sorting+reagent routing without specific specific moving parts; specific specific Quake large-scale integration LCI enabling specific specific thousands of microchamber on specific specific cm^2 chip); SPECIFIC PATENTABLE FABRICATION INNOVATIONS: specific novel chip material beyond PDMS (specific specific NOA81 thiol-ene optical adhesive UV cure for specific specific solvent resistance + specific specific biological compatibility; specific specific COC cyclic olefin copolymer hot emboss for specific specific low autofluorescence optical application; specific specific glass etching KOH for specific specific >99°C compatibility) with specific measured performance metric (specific solvent resistance + specific specific optical transmission + specific specific mass-production cost/chip); DROPLET MICROFLUIDICS PATENTS: ISOGEN; DROPWORKS; STILLA TECHNOLOGIES; BIORAD; RAINDANCE (BIORAD); 10X GENOMICS; EMULSIBIO: specific droplet generation (specific specific T-junction or specific specific flow-focusing geometry: specific specific oil-water-oil channel confluence for specific specific Poisson distribution 1-100pL emulsion droplet at specific specific 1-100kHz generation rate; specific specific surfactant 1H,1H,2H,2H-perfluoro-1-octanol or specific specific FluoroSurfactant HFE-7500 for specific specific droplet stability for specific specific >1h thermal cycling; specific specific DEP dielectrophoresis for specific specific active droplet sorting at specific specific 1kHz from specific specific fluorescence signal); specific droplet digital PCR (specific specific 20,000-1,000,000 partition/well Poisson distribution absolute copy number without specific specific standard curve; specific specific fluorescence endpoint reading from specific specific thermal cycled positive vs. specific specific negative droplet fraction); DIGITAL PCR CHIPS: BIORAD: specific QX200 ddPCR (specific specific flow-focusing chip for specific specific 20,000 droplets/20μL sample in specific specific <90s; specific specific endpoint fluorescence reading 2-color FAM+HEX for specific specific absolute quantitation ctDNA+CNV+gene expression); STILLA TECHNOLOGIES: specific Crystal Digital PCR (specific specific nanoplate 25,000 partition crystal solid-state for specific specific higher partition count vs. specific specific droplet); FLUIDIGM: specific Digital Array IFC (specific specific PDMS pressurized partition 765-chamber for specific specific 48 samples×48 assays parallel).

Organ-on-a-chip systems that recapitulate tissue and organ physiology; and single-cell genomics chips that enable massively parallel single-cell profiling are two of the highest-growth lab-on-chip application areas with significant active patent filings: ORGAN-ON-A-CHIP PATENTS: EMULATE INC. (WYSS INSTITUTE HARVARD); MIMETAS; CN BIO INNOVATIONS; HESPEROS; TISSUSE; CELLASYS; MICROFLUIDICS INTERNATIONAL: specific organ-on-a-chip microdevice (specific specific multi-layer microfluidic chip with specific specific porous ECM-coated membrane interface between specific specific epithelial + specific specific endothelial cells: specific specific PDMS chip bonded polycarbonate membrane 10μm pore 50μm for specific specific lung-chip air-liquid interface; specific specific PTFE membrane for specific specific gut epithelial polarization; specific specific integrated mechanical actuator 10% cyclic stretch 0.2Hz mimicking specific specific lung breathing mechanics or specific specific intestinal peristalsis; specific specific Wyss/Emulate lung-chip = first FDA ISTAND review for specific specific drug safety study alternative to specific specific animal study 2021; specific specific gut-chip microbiome integration host-microbe co-culture anaerobic bacteria + specific specific aerobic human cell in specific specific 37°C 5%CO2); specific multi-organ body-on-chip (specific specific 4-organ: specific specific liver+gut+brain+kidney connected via specific specific microfluidic circuit for specific specific systemic drug PK/PD simulation; specific specific tissue-engineered 3D organoid in specific specific organ compartment; specific specific recirculating media for specific specific first-pass liver metabolism→systemic distribution→target organ); SPECIFIC PATENTABLE ORGAN-ON-CHIP INNOVATIONS: specific novel organ-specific chip architecture (specific specific liver sinusoid: specific specific hepatocyte+Kupffer+stellate cell triculture in specific specific zonation gradient microphysiological system for specific specific DILI drug-induced liver injury prediction AUROC>0.85 vs. specific specific 2D hepatocyte); specific novel mechanical actuation method + specific measured organ physiology metric (specific permeability Papp; specific specific cytokine IL-6+TNF-α; specific specific mucus thickness); SINGLE-CELL SEQUENCING CHIP PATENTS: 10X GENOMICS: specific Chromium controller + specific specific GEM chip (specific specific 8-lane PDMS chip for specific specific gel bead + specific specific cell co-encapsulation at specific specific 1 cell/droplet targeting by specific specific Poisson loading; specific specific barcoded oligo 3M+barcode library from specific specific split-pool synthesis for specific specific 10-base cell barcode + specific specific 10-base UMI unique molecular identifier for specific specific PCR duplicate removal; specific specific multi-omic: specific specific Multiome ATAC+GEX simultaneous chromatin accessibility + specific specific gene expression from specific specific same nucleus); PARSE BIOSCIENCES (SPLIT-POOL LIGATION): specific combinatorial indexing (specific specific in-situ RNA-seq: specific specific cell fixation + specific specific 3-round split-pool ligation round 1+2+3 for specific specific 3-index cell barcode without specific specific microfluidic droplet for specific specific 1M+ cell profiling at specific specific lower cost/cell); VIZGEN; 10X XENIUM; NANOSTRING COSMX: specific spatial transcriptomics chip (specific specific FFPE tissue on specific specific flow cell for specific specific in-situ sequencing or specific specific fluorescent ISH smFISH for specific specific single-cell spatial gene expression).

Lab-on-chip startups face a complex IP environment dominated by academic spinouts with foundational patents; platform companies with deep portfolios; and the challenge of building on PDMS/soft lithography methods that are widely known but often poorly protected in commercial contexts: LAB-ON-CHIP STARTUP IP STRATEGY: UNDERSTAND THE LOC IP LANDSCAPE: FOUNDATIONAL ACADEMIC IP LICENSED: core PDMS multilayer soft lithography (Quake/Caltech+Stanford) and core droplet microfluidics methods are either expired or held by academic licensees — commercial players must build on top of these with specific chip geometries; assay chemistries; readout methods; and application-specific workflows; PLATFORM CONCENTRATION: 10x Genomics has used aggressive IP enforcement (multiple ITC/district court suits vs. Vizium+Parse+NanoString+Bio-Rad) to protect single-cell platform IP — new entrants in single-cell must conduct careful FTO and design around; Illumina holds deep sequencing chip IP — flow cell design; cluster generation; fluorescent nucleotide chemistry = heavily protected; REGULATORY PATHWAY CREATES MOAT: organ-on-a-chip = FDA ISTAND review pathway (2021) for drug safety study alternative — regulatory submission completion = commercial barrier; diagnostic LOC = FDA 510(k)/PMA required; WHEN TO PATENT IN LAB-ON-CHIP: SPECIFIC NOVEL CHIP GEOMETRY OR MATERIAL: specific novel channel geometry (specific T-junction/flow-focusing/step emulsification variant) with specific measured droplet size distribution CV + specific specific generation rate + specific specific droplet stability duration at specific specific temperature; SPECIFIC NOVEL FABRICATION PROCESS: specific novel chip material or specific specific bonding method with specific measured optical transmission + specific specific solvent resistance + specific specific production cost/chip vs. specific specific PDMS baseline; SPECIFIC NOVEL VALVE OR CONTROL ELEMENT: specific novel active element (DEP/acoustic/thermal/magnetic) with specific measured actuation speed + specific specific energy per actuation + specific specific sorting accuracy; SPECIFIC NOVEL SINGLE-CELL CAPTURE OR BARCODING: specific novel encapsulation method or specific specific combinatorial indexing scheme with specific measured cell capture efficiency % + specific specific doublet rate % + specific specific transcriptome coverage genes detected/cell; SPECIFIC NOVEL ORGAN-ON-CHIP: specific novel organ-mimetic architecture with specific specific cell type combination + specific specific ECM composition + specific specific measured organ function metric vs. specific specific 2D culture or specific specific animal model baseline; § 101: hardware chip device = fully eligible; algorithm for data analysis = potential abstract idea risk → anchor to specific chip + measured diagnostic output; TRADE SECRETS: specific manufacturing process yield; specific specific surface chemistry protocol; specific specific chip bonding conditions; KEY FTO: 10x Genomics GEM droplet single-cell barcode (500+; active enforcement); Illumina bridge amplification+SBS+ExAmp+patterned flow cell; Fluidigm IFC PDMS multilayer valve; Bio-Rad QX200 ddPCR droplet generation+endpoint reading; Emulate lung-chip ECM membrane+stretch actuation; PacBio ZMW; Oxford Nanopore protein pore+ASIC.